title: Erythropoietin and hepatitis C therapy: useful adjuvant therapy but remember to treat the patient and not just a number.
authors.forename: Eric M
authors.initials: EM
authors.lastname: Yoshida
authors.forename: Anne
authors.initials: A
authors.lastname: Dar Santos
authors.forename: Nilufar
authors.initials: N
authors.lastname: Partovi
authors.forename: Jo-Ann E
authors.initials: JA
authors.lastname: Ford
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D004921:Erythropoietin / Q000627:therapeutic use*; D016174:Hepacivirus / Q000472:pathogenicity; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D012254:Ribavirin; D007372:Interferons